Chris McLendon
Impact in
- Neurology top 1%
- Parkinson's Disease Mechanisms and Treatments
- Neurological diseases and metabolism
- Neuroinflammation and Neurodegeneration Mechanisms
- Neurological Disease Mechanisms and Treatments
- Physiology top 2%
- Alzheimer's disease research and treatments
Papers in
-
- Parkinson's Disease Mechanisms and Treatments 3
- Neurological Disorders and Treatments 2
-
- Alzheimer's disease research and treatments 7
- Co-authors
- Tom Thomas (2 shared papers)George R Thomas (3 shared papers)Rosa Canet-Aviles (3 shared papers)Mark Cookson (3 shared papers)MICHAEL J. MULLAN (1 shared paper)Rili Ahmad (2 shared papers)Melisa J. Baptista (2 shared papers)David W. Miller (2 shared papers)
- Journals
- The FASEB Journal (2 papers)Neuroreport (2 papers)Neurobiology of Disease (2 papers)ACS Synthetic Biology (1 paper)Nature (1 paper)
- Partner nations
- United StatesBulgariaJapan
In The Last Decade
Chris McLendon
16 papers receiving 2.6k citations
Chris McLendon's Hit Papers
Peers
Comparison fields: 5 of 105
- Neurology 1.0k
- Neurology 538
- Physiology 1.1k
- Cellular and Molecular Neuroscience 612
- Clinical Biochemistry 127
Countries citing papers authored by Chris McLendon
This map shows the geographic impact of Chris McLendon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris McLendon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris McLendon more than expected).
Fields of papers citing papers by Chris McLendon
This network shows the impact of papers produced by Chris McLendon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris McLendon. The network helps show where Chris McLendon may publish in the future.
Co-authors
The 25 scholars most cited alongside Chris McLendon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization Hit paper breakdown → | 2004 | 942 |
| 2 | 1996 | 620 | |
| 3 | 2002 | 371 | |
| 4 | 2006 | 296 | |
| 5 | 2003 | 206 | |
| 6 | 2000 | 96 | |
| 7 | 1997 | 55 | |
| 8 | 2003 | 33 | |
| 9 | 2015 | 26 | |
| 10 | 1997 | 25 | |
| 11 | 1998 | 24 | |
| 12 | 2020 | 14 | |
| 13 | 2003 | 4 | |
| 14 | 2018 | 4 | |
| 15 | 2024 | 3 | |
| 16 | 2025 | 1 |
About Chris McLendon
Chris McLendon is a scholar working on Neurology, Physiology, Neurology, Molecular Biology and Nutrition and Dietetics, having authored 16 papers that have together received 2.7k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (7 papers), Advanced biosensing and bioanalysis techniques (5 papers), Parkinson's Disease Mechanisms and Treatments (3 papers), Neurological Disorders and Treatments (2 papers), Neuroscience and Neuropharmacology Research (2 papers), Biosensors and Analytical Detection (2 papers), Trace Elements in Health (2 papers) and Cholinesterase and Neurodegenerative Diseases (2 papers). The work is most often cited by research in Neurology (1.0k citations), Neurology (538 citations), Physiology (1.1k citations), Cellular and Molecular Neuroscience (612 citations) and Clinical Biochemistry (127 citations). Chris McLendon has collaborated with scholars based in United States, Bulgaria and Japan. Frequent co-authors include Tom Thomas, George R Thomas, Rosa Canet-Aviles, Mark Cookson, MICHAEL J. MULLAN, Rili Ahmad, Melisa J. Baptista, David W. Miller, Mark A. Wilson and Gregory A. Petsko. Their work appears in journals such as The FASEB Journal, Neuroreport, Neurobiology of Disease, ACS Synthetic Biology and Nature.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.